Smoldering multiple myeloma. [N Engl J Med. 1980]

SearchDatabase nameforSearch term

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

1: N Engl J Med. 1980 Jun 12;302(24):1347-9.Links

Smoldering multiple myeloma.

PMID: 7374679 [PubMed - indexed for MEDLINE]

[Smoldering multiple myeloma]
Rev Clin Esp. 1985 May; 176(9):469-70.

[Rev Clin Esp. 1985]
Review[Smoldering multiple myeloma]
Ryoikibetsu Shokogun Shirizu. 1998; (22 Pt 3):422-6.

[Ryoikibetsu Shokogun Shirizu. 1998]
[Multiple myeloma--an analysis of 42 cases and review of the Chinese medical literature on 522 cases]
Zhonghua Zhong Liu Za Zhi. 1985 May; 7(3):207-10.

[Zhonghua Zhong Liu Za Zhi. 1985]
Smouldering multiple myeloma.
Haematologica. 1981 Dec; 66(6):880-2.

[Haematologica. 1981]
ReviewMonoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Blood Rev. 2007 Sep; 21(5):255-65. Epub 2007 Mar 26.

[Blood Rev. 2007]
» See reviews... | » See all...

Seven-year median time to progression with thalidomide for smoldering myeloma: partial response identifies subset requiring earlier salvage therapy for symptomatic disease.
Barlogie B, van Rhee F, Shaughnessy JD Jr, Epstein J, Yaccoby S, Pineda-Roman M, Hollmig K, Alsayed Y, Hoering A, Szymonifka J, et al. Blood. 2008 Oct 15; 112(8):3122-5. Epub 2008 Jul 31.

[Blood. 2008]
Review of thalidomide in the treatment of newly diagnosed multiple myeloma.
Cavallo F, Boccadoro M, Palumbo A. Ther Clin Risk Manag. 2007 Aug; 3(4):543-552.

[Ther Clin Risk Manag. 2007]
Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma.
Dispenzieri A, Kyle RA, Katzmann JA, Therneau TM, Larson D, Benson J, Clark RJ, Melton LJ 3rd, Gertz MA, Kumar SK, et al. Blood. 2008 Jan 15; 111(2):785-9. Epub 2007 Oct 17.

[Blood. 2008]
» See all...

Your browsing activity is empty.

Activity recording is turned off.

Display Show